TAKE PROFITS ON SMITH & NEPHEW AND EXIT THE POSITION $SNN $MDT $SYK $COV $JNJ

One of the rumored suitors of  SNN has been MDT. MDT just bought COV and is now likely out of the race to buy SNN. There are still other suitors of SNN such as SYK ...
Read more »

SMITH & NEPHEW HITS $100 TARGET $SNN $SYK $MDT

This post was just published on ZYX Buy Change Alert. SNN  hit $100 target yesterday afternoon on rumors that MDT would make a bid.  SNN is long from $81.40. There are more synergies in a buyout by SYK.  ...
Read more »

You are receiving less than 2% of the content from our paid services ...TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE 30 day trial.

Check out our enviable performance in both bull and bear markets.

26 WAYS TO PROFIT FROM ‘OBAMACARE’ $WLP $HCA $CYH $UHS $WCG $HUM $CNC $MRK $LLY $PFE $MDT $STJ

Obama has been re-elected; “Obamacare” is the law of the land. It doesn't matter if you agree or disagree with Obamacare, you might as well generate big profits from it. Obamacare has been profitable for us. ...
Read more »

ANATOMY OF $BSX (BOSTON SCIENTIFIC), $MDT (MEDTRONIC) AND $STJ (ST. JUDE MEDICAL) TRADES BASED ON ZYX CHANGE METHOD

In ZYX Change Method, every trade must pass through six screens. In the first Change Screen, we are looking for macro changes. In this case, our long time readers know that we have ...
Read more »

You are receiving less than 2% of the content from our paid services ...TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE 30 day trial.

Check out our enviable performance in both bull and bear markets.

AS PER THE PRIOR POST, ADDED TO $MDT SHORT AT $46.00

www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of ...
Read more »

SHORT SELL $STJ AND $MDT, BUY $BSX

$BSX is down substantially on FDA issues and competitors $MDT and $STJ have spiked up. These are minor paperwork issues and will not have a long term impact. Scale in on $BSX on dips. Scale ...
Read more »

UPDATE ON OPEN INDIVIDUAL STOCK POSITIONS

We are exiting $BCRX and $AVAV; please see separate posts for the reasons.We are short on $ACOR with average price of $30.28. Our thesis has not changed in that Ampyra is not a very good ...
Read more »

AGRESSIVELY ADDED TO SHORT POSITION ON $MDT (MEDTRONICS) AT $43.60

$MDT (Medtronics) earnings were better than expected, however a review of the earnings report does not change our medium term thesis. Unless our methodology tells us otherwise, we will use spikes up to add ...
Read more »

$BSX (BOSTON SCIENTIFIC) EARNINGS CONFIRM OUR SHORT SELL THESIS

We have been short on $MDT (Medtronics) with the first scale in at $36.20 and more aggressive entry at $38.00. $BSX earnings show weakness in both stents and implantable cardiac devices. Going forward ...
Read more »

CONSIDER SHORT SELL ON MDT (MEDTRONICS)

Consider start scaling in a short position in MDT right here at $36.20. MDT had passed all of our screens for a short sale, but we had been waiting for a trigger that the market ...
Read more »
Follow

Get every new post delivered to your Inbox

Join other followers

X

Unrivaled Performance In Bull And Bear Markets. FREE TRIALS. Subscribe Now!

¤